Debating the Best Treatment for Early Prostate Cancer: Surgery, Radiation, or Neither - 2021 Annual Meeting is organized by American Society for Radiation Oncology (ASTRO).
Course opens: 03/01/2022
Course expires: 02/28/2025
Description:
This course involves a case-based discussion with a panel of experts to review the various treatment options for early stage prostate cancer, including active surveillance, radical prostatectomy, external beam radiotherapy (including intensity modulated radiation therapy and stereotactic body radiation therapy), brachytherapy, and proton beam therapy. Each modality is discussed in the context of the impact on patient-centered quality of life.
Learning Objectives:
Upon completion of this activity, participants should be able to:
Accreditation
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
1.00 Certificate of Attendance
This activity was designated for 1.00 AMA PRA Category 1 Credit™.
1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved